ExpreS2ion Biotechnologies is a biotechnology company specializing in the development of innovative vaccines and immunotherapies. Utilizing its clinically validated ExpreS2 platform, the company focuses on advancing a pipeline that includes a lead breast cancer vaccine currently in Phase I trials. Based in Hørsholm, Denmark, ExpreS2ion aims to deliver cutting-edge solutions to address unmet medical needs in the field of immunotherapy.
Leadership & Board
Currently, no data available
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$12M
Total Amount Raised$12M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$12M
Latest Funding Amount$12M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.